CARPE DIEM - Seize the day

............Gather ye rosebuds as ye may!

The Mission of Pittencrieff Glen Associates is LEADERSHIP DEVELOPMENT

“It is not just what you do that counts ... it matters how you do it!”

E-mail:
[email protected]
Telephone:
1-908-781-0127

Our Leadership Coaches are Senior executives with multi-disciplinary backgrounds and multi-industry experience.

They are available to provide the boards of directors, CEO's and/or senior management of small and mid-size companies in areas such as:

Board Membership
Leadership Coaching & Counselling

Leadership Team Development
Leadership Training
Speaking Engagements

LEADERSHIP PRINCIPLES

To be successful, a business leader must be effective in:

Creating an agenda
Developing a human network for achieving the agenda
Execution / Implementation

ABOUT ME:

Douglas G. Watson is the founder of Pittencrieff Glen Associates, which was established in June, 1999. Prior to this, he was President and Chief Executive Officer of Novartis Corporation, the US subsidiary of Novartis A.G.

Watson’s career spanned 34 years with Geigy / Ciba-Geigy / Novartis.
He joined Geigy (UK) Ltd in 1966, working first in Operations Research and then in Corporate Planning.
Following the Ciba-Geigy merger, he spent one year in Basel, Switzerland as one of the UK representatives to the international integration team.
He returned to the UK in 1973 as accounting development and investment appraisal manager, and subsequently headquarters management accountant.
In 1978, Doug returned to Basel as personal assistant to the Chairman of the Executive Committee.
In 1981, he joined the Ciba-Geigy US Pharmaceuticals Division as senior vice president of planning and business development, and a member of the Pharmaceuticals Management Committee.
From 1986, he was President of Ciba US Pharmaceuticals Division until 1996, when he was appointed President & CEO of Ciba-Geigy Corporation.
During this ten year period, Mr. Watson was an active member of the Pharmaceutical Research & Manufacturers Association (PhRMA) board in Washington, DC.
Watson became President & CEO of Novartis Corporation in 1997, when Ciba-Geigy & Sandoz merged.
Watson elected to take early retirement from Novartis in May, 1999.

Mr. Watson currently serves as a member of the advisory board of Cancer Expert Now.

Prior board memberships included:

Ciba-Geigy Corporation
Novartis Corporation
Engelhard Corporation
Summit Bank Corporation
OraSure Technologies Inc.
Wright Medical Group Inc.
BioMimetic Therapeutics Inc.
BZL Inc.
Delcath Systems Inc.
Dendreon Corporation
Genta Inc.
Javelin Pharmaceuticals Inc.
Principia Pharmaceuticals Inc.
BioElectronics Inc.
InforMedix Inc.
ImmunSYS Inc.
Bionor Immuno AS
ValiGen N.V.

Non-Profit Foundations

Over the years, he has served as a member of the board for various non-profit foundations, including:

• American Liver Foundation
• America’s Promise - The Alliance for Youth
• Freedom House Foundation
• New York Floating Hospital
• Summit Speech School

Born near Pittencrieff Glen

Born near Pittencrieff Glen in the city of Dunfermline, Scotland, Mr. Watson:
• has an MA degree in Pure Mathematics from Churchill College, Cambridge University
• and is a member of the Chartered Institute of Management Accountants.